药明康德
(603259)
| 流通市值：1074.52亿 | | | 总市值：1237.87亿 |
| 流通股本：25.46亿 | | | 总股本：29.33亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 13,764,058,665.13 | 9,448,561,845.32 | 9,586,681,448.8 | 9,869,091,597.48 |
| 衍生金融资产 | 414,035,113.41 | 14,298,217.95 | - | 188,132,233.94 |
| 应收票据及应收账款 | 7,921,577,166.99 | 7,606,470,570.23 | 7,812,989,209.67 | 6,698,200,535.85 |
| 其中：应收票据 | 20,196,868.46 | 843,225.02 | 8,348,037.1 | 73,000,000 |
| 应收账款 | 7,901,380,298.53 | 7,605,627,345.21 | 7,804,641,172.57 | 6,625,200,535.85 |
| 预付款项 | 243,663,367.83 | 264,018,875.09 | 308,890,596.45 | 339,891,027.62 |
| 其他应收款合计 | 168,176,303.89 | 69,373,421.65 | 85,140,030.62 | 104,847,325.81 |
| 其中:应收利息 | 10,174,736.26 | - | - | - |
| 存货 | 4,736,229,956.28 | 5,293,440,871.4 | 5,715,495,649.77 | 5,843,131,558.12 |
| 合同资产 | 1,234,393,855.26 | 1,276,675,259.39 | 1,234,326,928.41 | 1,132,980,214.61 |
| 一年内到期的非流动资产 | 785,779,534.14 | 1,674,979,863.08 | 1,659,380,705.54 | 2,204,992,328.98 |
| 其他流动资产 | 1,143,553,809.85 | 919,298,660.64 | 1,095,553,208.09 | 1,040,396,236.31 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 30,422,470,960.82 | 29,777,189,611.66 | 27,580,065,949.01 | 27,502,389,642.3 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,215,629,616.25 | 1,162,875,678.36 | 1,174,029,758.84 | 1,150,568,600.72 |
| 其他非流动金融资产 | 8,626,009,050.68 | 8,887,883,288.16 | 9,167,801,335.38 | 8,910,846,198.53 |
| 固定资产 | 17,189,915,307.85 | 15,717,972,879.31 | 15,597,005,721.34 | 14,576,009,099.57 |
| 在建工程 | 6,982,392,940.58 | 7,612,767,738.53 | 7,228,223,735.44 | 7,790,722,052.93 |
| 生产性生物资产 | 1,012,478,000 | 1,126,996,000 | 1,123,566,000 | 1,018,947,000 |
| 使用权资产 | 1,391,213,425.45 | 1,282,574,497.23 | 1,280,006,912.12 | 1,275,347,839.6 |
| 无形资产 | 1,863,800,704.15 | 1,910,683,093.47 | 1,896,792,564.91 | 1,892,782,935.28 |
| 商誉 | 1,820,872,684.75 | 1,872,069,798.24 | 1,882,694,729.77 | 1,824,895,982.02 |
| 长期待摊费用 | 1,679,721,310.08 | 1,691,012,787.63 | 1,728,608,297.24 | 1,746,530,457.28 |
| 递延所得税资产 | 366,691,216.7 | 622,464,416.82 | 567,343,834.48 | 425,308,448.28 |
| 其他非流动资产 | 98,154,089.81 | 94,791,448.52 | 92,994,892.15 | 73,740,368.11 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 43,246,878,346.3 | 41,982,091,626.27 | 41,739,067,781.67 | 40,685,698,982.32 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 73,669,349,307.12 | 71,759,281,237.93 | 69,319,133,730.68 | 68,188,088,624.62 |
| 流动负债: | | | | |
| 短期借款 | 3,667,059,680.42 | 4,631,117,062.62 | 4,017,317,062.63 | 4,186,904,159.62 |
| 衍生金融负债 | 501,871,397.56 | 1,154,568,048.86 | 1,026,910,214.8 | 138,719,624.51 |
| 应付票据及应付账款 | 1,645,321,546.91 | 2,201,394,873.03 | 2,043,296,211.84 | 2,010,942,354.79 |
| 其中：应付票据 | - | - | - | 3,357,519.03 |
| 应付账款 | 1,645,321,546.91 | 2,201,394,873.03 | 2,043,296,211.84 | 2,007,584,835.76 |
| 合同负债 | 1,955,363,182.24 | 2,297,181,339.21 | 3,188,409,562.75 | 3,586,861,135.7 |
| 应付职工薪酬 | 2,125,635,919.87 | 1,880,579,476.89 | 1,571,355,542.28 | 1,354,982,878.24 |
| 应交税费 | 1,373,741,119.25 | 1,306,381,870 | 979,294,247.72 | 745,543,466.09 |
| 其他应付款合计 | 3,192,265,947.14 | 3,307,164,521.77 | 3,336,014,724.02 | 3,484,870,904.62 |
| 其中:应付利息 | 22,292,809.61 | 14,632,484.48 | 5,306,391.76 | 3,017,878.44 |
| 一年内到期的非流动负债 | 295,037,372.18 | 200,744,379.08 | 200,561,753.25 | 277,391,187.06 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 14,756,296,165.57 | 16,979,131,571.46 | 16,363,159,319.29 | 15,786,215,710.63 |
| 非流动负债: | | | | |
| 长期借款 | 687,016,640.84 | 356,647,794.99 | 397,856,527.93 | 189,849,246.19 |
| 租赁负债 | 1,098,552,195.37 | 1,072,207,593.97 | 1,064,926,935.52 | 1,074,791,032.39 |
| 递延收益 | 1,079,932,389.7 | 963,800,536.87 | 885,096,387.99 | 894,722,849.01 |
| 递延所得税负债 | 530,106,502.9 | 399,091,348.31 | 409,312,948.69 | 411,448,132.53 |
| 其他非流动负债 | - | - | - | 59,128.71 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 3,395,607,728.81 | 2,791,747,274.14 | 2,757,192,800.13 | 2,570,870,388.83 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 18,151,903,894.38 | 19,770,878,845.6 | 19,120,352,119.42 | 18,357,086,099.46 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,968,844,903 | 2,968,655,855 | 2,968,121,930 | 2,967,323,062 |
| 资本公积 | 28,401,011,161.7 | 27,671,143,598.13 | 27,462,800,764.13 | 27,223,109,328.13 |
| 减:库存股 | 3,156,528,928.12 | 3,808,464,330.99 | 2,626,678,349.31 | 2,728,309,132.99 |
| 其他综合收益 | 112,305,624.84 | -511,160,990.28 | -482,150,772.16 | 5,475,431.45 |
| 盈余公积 | 1,023,342,127.82 | 702,680,509.92 | 702,680,509.92 | 702,680,509.92 |
| 未分配利润 | 25,773,479,021.49 | 24,563,798,665.23 | 21,800,511,208.41 | 21,304,603,428.61 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 55,122,453,910.73 | 51,586,653,307.01 | 49,825,285,290.99 | 49,474,882,627.12 |
| 少数股东权益 | 394,991,502.01 | 401,749,085.32 | 373,496,320.27 | 356,119,898.04 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 55,517,445,412.74 | 51,988,402,392.33 | 50,198,781,611.26 | 49,831,002,525.16 |
| 负债和股东权益合计 | 73,669,349,307.12 | 71,759,281,237.93 | 69,319,133,730.68 | 68,188,088,624.62 |
| 公告日期 | 2024-03-19 | 2023-10-31 | 2023-08-01 | 2023-04-25 |
| 审计意见(境内) | 标准无保留意见 | | | |